04:15 PM EDT, 08/05/2025 (MT Newswires) -- Amgen ( AMGN ) reported fiscal Q2 non-GAAP net income late Tuesday of $6.02 per diluted share, up from $4.97 a year earlier

Analysts polled by FactSet expected $5.28.

Revenue for the quarter ended June 30 was $9.18 billion, up from $8.39 billion a year earlier.

Analysts expected $8.94 billion.

For fiscal 2025, the company raised adjusted EPS guidance to a range of $20.20 to $21.30 from the previous range of $20 to $21.20. Revenue projection for the fiscal year was also raised to $35 billion to $36 billion from a range of $34.3 billion to $35.7 billion.

Analysts are looking for $20.90 and $35.38 billion, respectively.